TCL Archive Cooperative Groups Won’t Get Grants For Head & Neck Cancer, Must Compete For Contract Awards July 1, 1977
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Mendelsohn Defends ImClone’s Actions And His Role In Development of C225 October 18, 2002
TCL Archive Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”. April 7, 2006
